Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Patients with Primary Cutaneous Melanoma
CP-GEP demonstrated good prognostic performance, particularly for patients with pT1b-pT2a melanoma and thus could be considered a noninvasive alternative for a SLNB.
Authors
- Bart A. van de Wiel (ORCID: https://orcid.org/0000-0001-7716-3308)
- Lisanne P. Zijlker (ORCID: https://orcid.org/0000-0002-1483-0625)
- Michel W.J.M. Wouters (ORCID: https://orcid.org/0000-0001-6173-0662)
- Winan J. van Houdt (ORCID: https://orcid.org/0000-0002-2303-3468)
- Alexander C. J. van Akkooi (ORCID: https://orcid.org/0000-0002-3262-6935)
- Anke Kuijpers
- Zahra Verwer
Institutions
- Leiden University Medical Center (NL)
- Melanoma Institute Australia (AU)
- Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1245/s10434-025-18928-9
- Citations
- 1
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.05